Antibody Therapeutics for Life

Notices


No Title Written by Written date Inquire
15   Dr. Jin-San Yoo, CEO of PharmAbcine is invited to present for ``Investor Relation`` at MIRAE ASSET DAEWOO SECURITIES Corporate Day on July 12th, 2017.   Admin   2019-01-14   432  
14   Interview of Dr. Jin-San Yoo, CEO of PharmAbcine with Bio-Pod   Admin   2019-01-14   492  
13   Dr. Jin-San Yoo, CEO of PharmAbcine is presenting at the forum for future pharm in Seoul on June 23, 2017.   Admin   2019-01-14   453  
12   Dr. Jin-San Yoo, CEO of PharmAbcine is presenting PharmAbcine`s R&D progress and the interim data of the ongoing phase IIa recurrent GBM trial at 2017 Bio International Convention in San Diego on June 19-22, 2017.   Admin   2019-01-14   460  
11   Dr. Lawrence Cher, principle investigator of Tanibirumab phase IIa recurrent GBM trial in Australia expose the interim data of the ongoing trial at ASCO 2017 Annual Meeting in Chicago on June 2-6, 2017.   Admin   2019-01-14   473  
10   Dr. Jin-San Yoo, CEO of PharmAbcine is invited to present PharmAbcine`s R&D progress at BIO LOGISTICS WORLD KOREA in Seoul on May 23-24, 2017.   Admin   2019-01-14   481  
9   Dr. Jin-San Yoo, CEO of PharmAbcine is serving as an expert of MAB working group of EDQM observer representing Republic of Korea.   Admin   2019-01-14   483  
8   Dr. Jin-San Yoo, CEO of PharmAbcine is serving as an officer for Bio at the Med term Strategy and planning for pharma industry.   Admin   2019-01-14   10,109  
7   Dr. Jin-San Yoo, CEO of PharmAbcine will be awarded for the contribution of Health-Medical by KHIDI President on April 13th, 2017.   Admin   2019-01-14   420  
6   Dr. Jin-San Yoo, CEO of PharmAbcine is invited to present at ``BizForum`` at BioKorea 2017.   Admin   2019-01-14   415